TLXTelix Pharmaceuticals Limited

$11.13

Who owns TLX

36 institutions reported holding TLX for 2026Q1, together 0.76% of the company, fewer than the 38 a quarter earlier.

36

Institutions reporting a position · as of 2026Q1 · down from 38 the quarter before

Shares held by institutions
2.6M

Shares held by institutions · 0.76% of the company · long US equity positions only, as reported on Form 13F

Reported value
$24M

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
0.54%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
6
New positions
10
Positions exited
12
Added to
17
Reduced
7
Top 10 holdersof the company
0.69%
Institutional ownership by quarter, 2024Q4 to 2026Q1
QuarterFilersSharesReported value
2026Q1362.6M$24M
2025Q4381.1M$8.4M
2025Q3270.8M$7.9M
2025Q2210.5M$7.3M
2025Q160.0M$799K
2024Q410.0M$57K
Largest reported holders, 2026Q1
HolderShares% of companyValue
FMR LLC0.6M0.17%$5.4M
Portolan Capital Management, LLC0.5M0.16%$5.2M
LAZARD ASSET MANAGEMENT LLC0.3M0.09%$2.8M
PORTLAND INVESTMENT COUNSEL INC.0.3M0.08%$2.5M
Private Advisor Group, LLC0.2M0.05%$1.7M
Integrated Wealth Concepts LLC0.2M0.05%$1.6M
Raiffeisen Bank International AG0.1M0.04%$1.2M
MORGAN STANLEY0.1M0.03%$1.1M
JPMORGAN CHASE & CO0.1M0.02%$514K
Mariner Wealth Advisors, LLC0.0M0.01%$415K

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…